Bedford, MA, United States of America

Deborah A Kinch

This inventor holds 1 USPTO granted patent. Top assignee: Homology Medicines, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah A Kinch. Retrieved from https://idiyas.com/inventor/deborah-a-kinch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Deborah A. Kinch

Introduction

Deborah A. Kinch is a notable inventor based in Bedford, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of genetic disorders. Her work focuses on innovative methods that address complex health issues.

Latest Patents

Kinch holds a patent for "Methods of treating phenylketonuria." This patent outlines methods for treating subjects with diseases or disorders associated with a PAH gene mutation. The methods involve administering a therapeutically effective dose of a recombinant adeno-associated virus (rAAV) that expresses a phenylalanine hydroxylase (PAH) polypeptide in a cell, thereby restoring PAH gene function in the subject. She has 1 patent to her name.

Career Highlights

Deborah A. Kinch is currently associated with Homology Medicines, Inc., where she continues to advance her research and innovations. Her work is pivotal in developing therapies that can significantly improve the quality of life for individuals with genetic disorders.

Collaborations

Some of her notable coworkers include Omar L. Francone and Diana Lamppu. Their collaborative efforts contribute to the success of the projects they undertake at Homology Medicines, Inc.

Conclusion

Deborah A. Kinch's contributions to the field of medicine through her innovative patent and collaborative work highlight her commitment to improving health outcomes for individuals with genetic disorders. Her ongoing research continues to pave the way for future advancements in treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…